Thomas Shrader

May 04, 2026

Thomas Shrader rated ACIU as Buy on May 04, 2026, setting a price target of 8. Shares have remained stable near 3.03, leaving the 8 target still in play.

Apr 24, 2026

On Apr 24, 2026, NTHI was given a Buy rating by Thomas Shrader, with a target price of 15. The stock traded sideways with a % move, keeping the bullish thesis unresolved.

Apr 20, 2026

CMPS received a Buy rating from Thomas Shrader on Apr 20, 2026, aiming for 14. Price action was muted, as shares hovered around 9.06 despite the bullish outlook.

Apr 17, 2026

On Apr 17, 2026, Thomas Shrader published a Buy outlook on HROW, with a target of 63. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 40.53.

Mar 30, 2026

Thomas Shrader on Mar 30, 2026 assigned DRUG a Buy rating, with a price target of 147. The Buy call aligned well with market performance, producing a gain of 28.49%.

Mar 26, 2026

On Mar 26, 2026, Thomas Shrader reaffirmed ABOS with a Buy rating, targeting 8. Market indecision has kept the 8 target in a holding pattern.

Mar 26, 2026

OVID was rated Buy by Thomas Shrader on Mar 26, 2026, with a price objective of 4. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

Mar 25, 2026

On Mar 25, 2026, Thomas Shrader initiated coverage on DNLI with a Buy rating and target of 38. The Buy call has yet to be validated as shares remain 19.28 away from the target.

Mar 24, 2026

Thomas Shrader issued a Buy recommendation for NRXP on Mar 24, 2026, price target set at 25. Investors following the Buy call captured upside momentum, with shares now at 2.98.

Mar 19, 2026

On Mar 19, 2026, STOK was evaluated by Thomas Shrader, who gave a Buy rating and target of 39. So far, the Buy call awaits clearer momentum, with shares flat at 32.72.

Mar 10, 2026

Thomas Shrader rated ALEC as Buy on Mar 10, 2026, setting a price target of 6. Shares have remained stable near 2.37, leaving the 6 target still in play.

Mar 02, 2026

On Mar 02, 2026, IRD was given a Buy rating by Thomas Shrader, with a target price of 12. The stock rallied 18.01% after the rating, narrowing the gap to the target of 12 and validating the bullish stance.

Feb 26, 2026

IVVD received a Buy rating from Thomas Shrader on Feb 26, 2026, aiming for 10. The rating hasn’t played out as hoped, with the stock trading 17.65% below expectations.

Feb 26, 2026

On Feb 26, 2026, Thomas Shrader published a Buy outlook on PCVX, with a target of 89. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 57.24.

Feb 17, 2026

Thomas Shrader on Feb 17, 2026 assigned ANRO a Buy rating, with a price target of 28. The Buy call aligned well with market performance, producing a gain of 33.23%.

Jan 20, 2026

On Jan 20, 2026, Thomas Shrader reaffirmed NVAX with a Buy rating, targeting 19. Market indecision has kept the 19 target in a holding pattern.

Nov 18, 2025

BHVN was rated Buy by Thomas Shrader on Nov 18, 2025, with a price objective of 16. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

Nov 13, 2025

On Nov 13, 2025, Thomas Shrader initiated coverage on COYA with a Buy rating and target of 16. The Buy call has yet to be validated as shares remain 11.77 away from the target.

Nov 10, 2025

Thomas Shrader issued a Buy recommendation for ALDX on Nov 10, 2025, price target set at 9. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Oct 22, 2025

On Oct 22, 2025, ARCT was evaluated by Thomas Shrader, who gave a Buy rating and target of 23. Investors saw limited payoff as shares fell short of the 23 target.

Oct 15, 2025

Thomas Shrader rated GANX as Buy on Oct 15, 2025, setting a price target of 9. Shares have remained stable near 1.89, leaving the 9 target still in play.